β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces. / Brown, James W P; Buell, Alexander K; Michaels, Thomas C T; Meisl, Georg; Carozza, Jacqueline; Flagmeier, Patrick; Vendruscolo, Michele; Knowles, Tuomas P J; Dobson, Christopher M; Galvagnion, Céline.
In: Scientific Reports, Vol. 6, 03.11.2016, p. 36010.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces
AU - Brown, James W P
AU - Buell, Alexander K
AU - Michaels, Thomas C T
AU - Meisl, Georg
AU - Carozza, Jacqueline
AU - Flagmeier, Patrick
AU - Vendruscolo, Michele
AU - Knowles, Tuomas P J
AU - Dobson, Christopher M
AU - Galvagnion, Céline
PY - 2016/11/3
Y1 - 2016/11/3
N2 - α-Synuclein is an intrinsically disordered protein that is associated with the pathogenesis of Parkinson's disease through the processes involved in the formation of amyloid fibrils. α and β-synuclein are homologous proteins found at comparable levels in presynaptic terminals but β-synuclein has a greatly reduced propensity to aggregate and indeed has been found to inhibit α-synuclein aggregation. In this paper, we describe how sequence differences between α- and β-synuclein affect individual microscopic processes in amyloid formation. In particular, we show that β-synuclein strongly suppresses both lipid-induced aggregation and secondary nucleation of α-synuclein by competing for binding sites at the surfaces of lipid vesicles and fibrils, respectively. These results suggest that β-synuclein can act as a natural inhibitor of α-synuclein aggregation by reducing both the initiation of its self-assembly and the proliferation of its aggregates.
AB - α-Synuclein is an intrinsically disordered protein that is associated with the pathogenesis of Parkinson's disease through the processes involved in the formation of amyloid fibrils. α and β-synuclein are homologous proteins found at comparable levels in presynaptic terminals but β-synuclein has a greatly reduced propensity to aggregate and indeed has been found to inhibit α-synuclein aggregation. In this paper, we describe how sequence differences between α- and β-synuclein affect individual microscopic processes in amyloid formation. In particular, we show that β-synuclein strongly suppresses both lipid-induced aggregation and secondary nucleation of α-synuclein by competing for binding sites at the surfaces of lipid vesicles and fibrils, respectively. These results suggest that β-synuclein can act as a natural inhibitor of α-synuclein aggregation by reducing both the initiation of its self-assembly and the proliferation of its aggregates.
KW - Amino Acid Sequence
KW - Binding, Competitive
KW - Hydrogen-Ion Concentration
KW - Lipids/chemistry
KW - Phosphatidylserines/chemistry
KW - Protein Aggregates
KW - Protein Aggregation, Pathological
KW - Protein Binding
KW - Sequence Alignment
KW - Surface Properties
KW - alpha-Synuclein/chemistry
KW - beta-Synuclein/chemistry
U2 - 10.1038/srep36010
DO - 10.1038/srep36010
M3 - Journal article
C2 - 27808107
VL - 6
SP - 36010
JO - Scientific Reports
JF - Scientific Reports
SN - 2045-2322
ER -
ID: 216263682